Immune checkpoint inhibitors modulate the cytotoxic effect of chemotherapy in lung adenocarcinoma cells

Immunotherapy using immune checkpoint inhibitors (ICIs) has significantly improved survival in patients with non-small cell lung cancer (NSCLC), and ICIs are increasingly used in combination with cytotoxic treatments, such as chemotherapy. Although combined treatments are more effective, not all pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Saar, Marika, Lavogina, Darja, Lust, Helen, Tamm, Hannes, Jaal, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018276/
https://www.ncbi.nlm.nih.gov/pubmed/36936028
http://dx.doi.org/10.3892/ol.2023.13738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018276/
https://www.ncbi.nlm.nih.gov/pubmed/36936028
http://dx.doi.org/10.3892/ol.2023.13738

Ejemplares similares